These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17884606)

  • 1. Walking decreased risk of cardiovascular disease mortality in older adults with diabetes.
    Bernsen RM; Nagelkerke NJ
    J Clin Epidemiol; 2007 Oct; 60(10):1090; author reply 1090-1. PubMed ID: 17884606
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of excess cardiovascular mortality in diabetes.
    Keen H; Ashton CE
    Postgrad Med J; 1989; 65 Suppl 1():S26-9. PubMed ID: 2695907
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemiology of walking and type 2 diabetes.
    Caspersen CJ; Fulton JE
    Med Sci Sports Exerc; 2008 Jul; 40(7 Suppl):S519-28. PubMed ID: 18562969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diabetes-cardiovascular risk paradox: results from a Finnish population-based prospective study.
    Barengo NC; Katoh S; Moltchanov V; Tajima N; Tuomilehto J
    Eur Heart J; 2008 Aug; 29(15):1889-95. PubMed ID: 18559404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine.
    Khalangot M; Tronko M; Kravchenko V; Kulchinska J; Hu G
    Heart; 2009 Mar; 95(6):454-60. PubMed ID: 18697804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women: response to Juutilainen et al.
    Targher G; Bertolini L; Zoppini G; Lippi G; Zenari L
    Diabetes Care; 2007 Jun; 30(6):e51; author reply e52. PubMed ID: 17526813
    [No Abstract]   [Full Text] [Related]  

  • 7. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease and intensive glucose lowering in type 2 diabetes.
    Younis N; Soran H; Hassanein M
    QJM; 2009 Apr; 102(4):293-6. PubMed ID: 19147659
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.
    Soedamah-Muthu SS; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetes and stroke].
    Heckmann JG; Lang C; Handschu R; Haslbeck M; Neundörfer B
    Dtsch Med Wochenschr; 2005 Feb; 130(6):291-6. PubMed ID: 15692906
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prognosis of adult-onset diabetes].
    Mykkänen L; Niskanen L
    Duodecim; 1990; 106(9):725-30. PubMed ID: 1670364
    [No Abstract]   [Full Text] [Related]  

  • 12. Pantalone et al.: the risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
    Bell DS
    Acta Diabetol; 2009 Jun; 46(2):155; author reply 157. PubMed ID: 19300899
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients.
    Targher G; Bertolini L; Zenari L; Lippi G; Pichiri I; Zoppini G; Muggeo M; Arcaro G
    Diabet Med; 2008 Jan; 25(1):45-50. PubMed ID: 18199131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes of mortality in diabetes mellitus: data from a tertiary teaching hospital in India.
    Zargar AH; Wani AI; Masoodi SR; Bashir MI; Laway BA; Gupta VK; Wani FA
    Postgrad Med J; 2009 May; 85(1003):227-32. PubMed ID: 19520872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and incidence of Type 2 diabetes and its complications 1996-2003--estimates from a Swedish population-based study.
    Ringborg A; Lindgren P; Martinell M; Yin DD; Schön S; Stålhammar J
    Diabet Med; 2008 Oct; 25(10):1178-86. PubMed ID: 19046196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate set to benefit from new research on its active metabolite, fenofibric acid.
    Cardiovasc J Afr; 2008; 19(3):171-2. PubMed ID: 18568186
    [No Abstract]   [Full Text] [Related]  

  • 17. Joint effects of history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease.
    Hu G; Jousilahti P; Tuomilehto J
    Eur Heart J; 2007 Dec; 28(24):3059-66. PubMed ID: 17981826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prevention of cardiovascular disease in people with dysglycemia.
    Bianchi C; Miccoli R; Penno G; Del Prato S
    Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetes mellitus in coronary bypass surgery: risks and chances. Treatment concepts for a particularly challenging group of patients].
    Lauruschkat AH; Ennker J
    Herz; 2008 Apr; 33(3):212-21. PubMed ID: 18568316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.